Category: News Feed

CCL believes in empowerment and well-being of it’s employees. In pursuit of this goal, a customized training session on Personal Effectiveness by Waleed Anwar – Carnelian was held at CCL for it’s employees. The training session was aimed at achieving...

CCL ensures a healthy work environment and a culture that holistically embraces well-being of it’s employees. Our shared services team recently toured Arang Kel in Kashmir, experienced breathtakingly beautiful sights, waterfalls and lush green valleys. During the course of two...

We pride ourselves for our people-centric culture and belief in a healthy work environment, that truly reflects health and happiness for our employees. Our business finance team recently toured Gilgit and Hunza, team members went sight seeing and collectively enjoyed...

A Trophy Distribution & VAC Ceremony was held at CCL Head Office to acknowledge the Teams for their excellent performance and participation in indoor Cricket Tournament and Futsal Fiesta Tournament. Dr. Shahzad (MD & CEO, CCL Pharmaceuticals) distributed Value Appreciation...

In Pakistan, every 1 out of 3 Adults suffer from Hypertension. Patients at the age of 40 afflicted with hypertension have become increasingly vulnerable to a wide range of diseases. 24 hour blood pressure control is vital to prevent hypertension...

Dr. Shahzad Khan, MD & CEO inaugurated our state-of-the-art R&D lab along with ExCom members; Muhammad Akram, Dr. Rizwan Mahmood, Dr. Qaddafi Jahangir, Hina Sarwat, Salman Malik and various other stakeholders. He admired the team work and collaboration that has...

LAHORE, JULY 2018:CCL’s Management Trainee Program was recently launched and shortlisting of candidates is underway to find future leaders who may be at the helm of CCL affairs in years to come. “We arequite happy at the rousing response received...

LAHORE, JULY 2018: CCL Pharmaceuticals recently launched the first ever ticagrelor in Pakistan in a ceremony held in a local hotel in Lahore. Ticagrelor is an FDA approved antiplatelet therapy to reduce blood clot formation, which significantly reduces cardiovascular events and deaths in...